why choose us

First received: September 16, 2023

Clinical Trial: YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Atherosclerotic Cardiovascular Disease

Study Type: INTERVENTIONAL


Official Title: A Phase I/IIa Trial to Evaluate the Safety, Tolerability, PK, and Preliminary Efficacy of Single and Multiple Ascending Doses of YN001 in Healthy Subjects and Multiple Ascending Doses of YN001 in

Brief Summary: This study consists of two parts.The SAD and MAD of part I are a randomized, double-blind, placebo-controlled, single and multiple ascending dose study in healthy adult subjects.The MAD expansion cohort of part I is single arm and multipal ascending dose in heallthy subjects.Part II (phase Ib/IIa) is a multicenter, randomized, controlled, open label, multiple ascending dose study in patients with coronary atherosclerosis.

Read more